TC BioPharm to Boost Treatment Capacity and Slash Costs with Advanced Manufacturing Process
The company's initiative aims to leverage its existing infrastructure to scale up production dramatically, projecting a surge from 52 patient treatments annually to over 1,000.
Global Pharma | 04/04/2024 | By Abha | 728
The acquisition is expected to accelerate Apotex's growth within the specialty branded pharmaceutical market, adding a diverse portfolio of over 60 products and a full-service branded pharmaceutical platform.
Global Pharma | 04/04/2024 | By Abha | 1382
Affinity Biosensors Gets FDA Clearance for LifeScale AST System
Affinity Biosensors, an innovator in the field of healthcare diagnostics, has declared that its groundbreaking LifeScale AST system has received FDA clearance.
Global Pharma | 04/04/2024 | By Aishwarya | 798
PTx Leukine Gets Approval From Japan PMDA to Treat aPAP
Partner Therapeutics, Inc. has announced that its partner, Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device Agency (PMDA) for the inhaled use of Leukine.
Global Pharma | 04/04/2024 | By Aishwarya | 1720
Olympus Announces FDA Clearance of RenaFlex, its First Single-use Flexible Ureteroscope
The RenaFlex single-use flexible ureteroscope system is used to access and visualize the urinary tract to diagnose and treat urinary diseases and disorders, such as kidney stones.
Global Pharma | 03/04/2024 | By Manvi | 352
FDA Grants FTD to RemeGen Telitacicept for Treatment of pSS
RemeGen Co. Ltd. Has received Fast Track Designation (FTD) by the US Food and Drug Administration (FDA) for its innovative BLyS/APRIL dual-target fusion protein drug.
Global Pharma | 03/04/2024 | By Aishwarya | 625
INTEGRA to Give Away Limited Edition EVOLVE Manual Pipette Starter Pack
INTEGRA Biosciences has announced to give away 10 custom-printed EVOLVE manual pipette starter packs that are sure to add color to any lab.
Global Pharma | 03/04/2024 | By Aishwarya | 787
Alembic Pharmaceuticals Receives USFDA Tentative Approval for Ribociclib Tablets
Alembic has a cumulative total of 197 Abbreviated New Drug Application (ANDA) approvals from the USFDA. Among these, 170 are final approvals, while 27 are tentative approvals.
Global Pharma | 03/04/2024 | By Abha | 877
Vanda Fanapt Receives FDA Approval for Acute Treatment of Bipolar I Disorder
Vanda Pharmaceuticals Inc. has announced that the US FDA has approved Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
Global Pharma | 03/04/2024 | By Aishwarya | 795
Eko Health Announces FDA Clearance for its Low EF Detection AI
This leap in early detection marks both a significant medical innovation and a new era in the detection of cardiovascular disease.
Global Pharma | 02/04/2024 | By Manvi | 804
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy